1. Home/
  2. Compounds/
  3. BRD-K27188169:navitoclax (2:1 mol/mol)

BRD-K27188169:navitoclax (2:1 mol/mol)


SourcesNames Used
CTRPv2BRD-K27188169:navitoclax (2:1 mol/mol)
PharmacoGx BRD-K27188169:navitoclax (2:1 mol/mol)

Cell lines tested with BRD-K27188169:navitoclax (2:1 mol/mol)

373 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
IGROV-1 ovary CTRPv22
P3HR-1 haematopoietic and lymphoid tissue CTRPv22
CAL-51 breast CTRPv22
NCI-H460 lung CTRPv22
NCI-H1299 lung CTRPv22
SUIT-2 pancreas CTRPv22
A375 skin CTRPv22
ZR-75-1 breast CTRPv21
YAPC pancreas CTRPv21
Download CSV

Tissues tested with BRD-K27188169:navitoclax (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv272
large intestineCTRPv227
central nervous systemCTRPv221
urinary tractCTRPv215
Download CSV
Download Data as CSV

Top molecular features associated with response to BRD-K27188169:navitoclax (2:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA THEM4 CTRPv2 AAC -0.28 7e-07
mRNA PSMB4 CTRPv2 AAC -0.24 2e-05
mRNA CFC1 CTRPv2 AAC -0.24 0.4
mRNA NBPF15 CTRPv2 AAC -0.23 1e-05
mRNA C1D CTRPv2 AAC -0.22 3e-05
mRNA OTUD7B CTRPv2 AAC -0.22 0.0003
mRNA CFC1B CTRPv2 AAC -0.21 0.4
mRNA MRPS21 CTRPv2 AAC -0.21 6e-05
mRNA MRPL24 CTRPv2 AAC -0.21 6e-05
mRNA PRELID1 CTRPv2 AAC -0.21 8e-05
Download CSV